| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +491K | 100% | $2.51 | +$1.23M |
| Sells | 0 | ||||
| Net | +3 | +491K | 100% | +$1.23M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| SANFORD ROBERTSON | Director | $25.2M | 16 May 2024 | ||
| REMI BARBIER | President & CEO, Director | $20.3M | 20 May 2024 | ||
| Richard Barry | President & CEO, Director | $12.7M | +$1.17M | +10.1% | 20 Nov 2025 |
| Robert Christopher Cook | Chief Operating & Legal Office | $1.73M | +$39.9K | +2.37% | 30 Sep 2025 |
| Freda Nassif | Chief Business Officer | $1.69M | 17 Apr 2025 | ||
| James William Kupiec | Chief Medical Officer | $1.69M | 29 Nov 2024 | ||
| Jaren Landen | Chief Clinical Dev. Officer | $1.43M | 18 Nov 2024 | ||
| ROBERT Z. GUSSIN | Director | $253K | 23 May 2025 | ||
| Robert Eugene Anderson Jr | Director | $194K | +$24.9K | +14.8% | 24 Nov 2025 |
| PATRICK J. SCANNON | Director | $169K | 23 May 2025 | ||
| Pierre Gravier | Director | $169K | 23 May 2025 | ||
| MICHAEL J. O. DONNELL | Director | $169K | 23 May 2025 | ||
| Claude Nicaise | Director | $169K | 23 May 2025 | ||
| Eric Schoen | Chief Financial Officer | $44.4K | 17 Apr 2025 | ||
| NADAV FRIEDMANN | Chief Medical Officer, Director | $2.5K | 31 Dec 2022 | ||
| Dawn Carter Bir | Director | 21 Oct 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|